Seroconversion and asymptomatic infections during oseltamivir prophylaxis against Influenza A H1N1 2009
Open Access
- 10 June 2010
- journal article
- research article
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 10 (1) , 164
- https://doi.org/10.1186/1471-2334-10-164
Abstract
Anti-viral prophylaxis is used to prevent the transmission of influenza. We studied serological confirmation of 2009 Influenza A (H1N1) infections during oseltamivir prophylaxis and after cessation of prophylaxis.This publication has 17 references indexed in Scilit:
- Outbreak of 2009 Pandemic Influenza A (H1N1) at a New York City SchoolNew England Journal of Medicine, 2009
- Household Transmission of 2009 Pandemic Influenza A (H1N1) Virus in the United StatesNew England Journal of Medicine, 2009
- How well are we managing the influenza A/H1N1 pandemic in the UK?BMJ, 2009
- Effectiveness of Neuraminidase Inhibitors for Preventing Staff Absenteeism during Pandemic InfluenzaEmerging Infectious Diseases, 2007
- Management of Influenza in Households: A Prospective, Randomized Comparison of Oseltamivir Treatment With or Without Postexposure ProphylaxisThe Journal of Infectious Diseases, 2004
- InfluenzaThe Lancet, 2003
- Zanamivir Prophylaxis: An Effective Strategy for the Prevention of Influenza Types A and B within HouseholdsThe Journal of Infectious Diseases, 2002
- Outbreak of Influenza in Highly Vaccinated Crew of U.S. Navy ShipEmerging Infectious Diseases, 2001
- Outbreak of Influenza in Highly Vaccinated Crew of U.S. Navy ShipEmerging Infectious Diseases, 2001
- Use of the Selective Oral Neuraminidase Inhibitor Oseltamivir to Prevent InfluenzaNew England Journal of Medicine, 1999